Legal & General Group
TTOO

Legal & General Group’s T2 Biosystems, Inc TTOO Stock Holding History

Legal & General Group’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1
Closed -$8K – 3430
2019
Q2 		$8K Hold
1
– – ﹤0.01% 3400
2019
Q1 		$13K Hold
1
– – ﹤0.01% 3211
2018
Q4 		$15K Hold
1
– – ﹤0.01% 3188
2018
Q3 		$38K Hold
1
– – ﹤0.01% 2911
2018
Q2 		$30K Buy
+1
New +$38K ﹤0.01% 3028
2017
Q2 		– Hold
0
– -$10K – 3393
2017
Q1 		– Sell
-1
Closed -$28.1K – 3194
2016
Q4 		$17K Buy
+1
New +$30.8K ﹤0.01% 3146

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Legal & General Group's TTOO Position: Q3 2019 in Review

Legal & General Group sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 1 share — an estimated $8K sold.

Legal & General Group first reported a position in TTOO in Q4 2016 and held it in 6 quarters. The position peaked at $38K in Q3 2018. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

  • Legal & General Group reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
  • Legal & General Group sold 1 T2 Biosystems, Inc share in Q3 2019, an estimated $8K.
  • Legal & General Group first reported a position in T2 Biosystems, Inc in Q4 2016 and held it in 6 quarters.
  • Legal & General Group's T2 Biosystems, Inc position peaked at $38K in Q3 2018.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on Legal & General Group's 13F filing for Q3 2019, filed 13 Nov 2019.